Luskin A, Griffin NM, Wagele-Steffen A, et al. Decreased exacerbations and hospitalizations in adolescents enrolled in PROSPERO (Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab). ATS 2017, abstract A5104.
Management van T-DXd-geassocieerde ILD bij HER2-positieve gemetastaseerde borstkanker
sep 2023 | Borstkanker, ILD